Director v AbbVie (AUTH/3074/9/18): Clinical trial disclosure complaint found outwith scope

📅 2018 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/3074/9/18
PartiesDirector v AbbVie
TopicClinical trial disclosure
Complaint received12 September 2018
Completed03 July 2019
Applicable Code year2016
OutcomeNo breach; outwith the scope of the Code
Clause(s)Outwith the scope of the Code
AppealNo appeal
Additional sanctionsNot stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A complaint was brought by the Director against AbbVie.
  • The subject matter related to clinical trial disclosure.
  • The case was assessed under the ABPI Code year 2016.
⚖️

Outcome

  • No breach of the ABPI Code was found.
  • The matter was ruled outwith the scope of the Code.
  • No appeal hearing took place (No appeal).
  • No case summary/report was published because it was outwith scope.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training